Bayer HealthCare / Press

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer’s Xarelto® in Patients with Non-Valvular Atrial Fibrillation

Bayer HealthCare and its development partner Janssen Pharmaceuticals, Inc. announced results from two real-world studies, XANTUS and a post-marketing safety surveillance (PMSS) study... more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.

  • TV Footage

    In this section you can find videos for editorial coverage. » more


    The video section provides an overview of interesting videos for viewing. » more

Bayer HealthCare Links

RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG